The multicentre observational study described 382 placements of catheters across 19 different institutions, recording the placement techniques and tracking resulting complications to determine the associated risk factors.
The majority of the data was collected by veterinary nurses across the country.
The risk factors identified included the number of insertion attempts, whether a second subsequent placement was required, the frequency that the catheter was flushed and if the flush solution was compound sodium lactate.
In addition to identifying the risk factors, the study also found that complications occurred in just over one-quarter of placements, with limb swelling and phlebitis being the most common (11.5%).
The second most common complication observed was PIVC dislodgement/patient interference (7.9%).
As a result of these findings, the researchers are calling for more vigilant monitoring of patients with a PIVC in situ, particularly if they have experienced any of the factors that increase their risk of complications.
Eleanor said: “PIVCs are placed every day in almost all veterinary practices, yet there is little evidence to inform how best to place and manage them.
"I am passionate about providing the best care for cats and dogs, and it was fantastic to work with like-minded nurses and vets who wanted to gather the evidence that we can use to improve the care of our patients.
"I look forward to continuing this area of research, and believe veterinary nurses are best placed to undertake this work as it is part our of daily working lives."
Dr Christopher Scudder, Senior Lecturer in Small Animal Internal Medicine at the Royal Veterinary College and senior author in the study, said: “The hope is that this study will stimulate more research about PIVCs, and that sufficient evidence will be developed to help reduce complications associated with these routinely placed devices.”
Reference
The Blue Cross and National Veterinary Services (NVS) are celebrating the success of a new initiative to generate additional saleable items for the charity, with the help of vet practices across the UK.
Earlier this year, The Blue Cross teamed up with NVS to launch a campaign to sign up vet practices who use NVS services to encourage their staff and clients to donate bags of unwanted clothes and bric-a-brac for the charity to sell and raise funds. This week saw the arrival of the 5,000th bag of donated items arrive at The Blue Cross warehouse
Jonathan Chambers Blue Cross spokesperson said: "We are extremely grateful to NVS, the vet practices taking part in the scheme and their clients. We are overwhelmed at the response so far and looking forward to receiving many more bags of goods in the future. Although the donated items may be unwanted possessions to some, each bag generates about £20 of income for us. This means the scheme has so far provided an amazing £100,000 worth of income towards helping sick and homeless animals in the care of The Blue Cross."
Caitrina Harrison, Sales & Marketing Director for NVS said: "We are delighted to be supporting The Blue Cross with this worthwhile initiative. We have an experienced and flexible logistics team, who have been able to help with the delivery and collection of the clothing bags throughout the UK. We have had excellent feedback from many veterinary practices who have got involved and the requests for clothing bags keep coming in."
Veterinary practices who receive their stock and drugs from NVS that are not yet part of The Blue Cross donation scheme can sign up now by contacting julie.godwin@nvs-ltd.co.uk or Jonathan Chambers at The Blue Cross: trading@bluecross.org.uk.
The International Federation on Ageing has published Companion Animals and the Health of Older Persons, a report described as the most extensive literature review to date of research undertaken in the field of companion animals and the health of older people, made possible through an educational sponsorship from Bayer Healthcare.
The report provides a comprehensive literature review into the ways pets contribute to the physical and mental health of individuals and the well-being of our broader society, citing studies which found:
Dr Jane Barratt from the International Federation on Ageing said: "This field of research has important implications across generations and also for the future of our broader society. Many studies have broadly discussed how pets, such as dogs and cats, contribute to health by reducing anxiety, loneliness and depression, but until today, have not yet been published in a single resource. This new report advances our understanding of the value of companion animals in the framework of human health and the broader society."
In the report, investigators acknowledge that the current data on human-companion animal interactions are often predicated on anecdotal evidence and scant qualitative and quantitative data, with poorly-constructed and poorly-controlled study design. This may account in part for the conflicting results found in a number of different studies. Nonetheless, they argue that based on current evidence of considerable positive potential for the health of older individuals, and the associated health and welfare benefits for local communities and societies, more research time and energy should be directed towards this area of research. In particular, they say, there should be much greater involvement from veterinary surgeons, who are well placed to be consulted in studies of companion animals and older people’s attachment, affection and bonding capacities, well-being and social capital.
Ferenc Polz, Head of Bayer Animal Health said: "The therapeutic benefit of companion animals is an area of study attracting increasing interest among health and social science professionals and this sponsored report is yet another example of the life changing potential of human and animal relationships."
The Worldwide Veterinary Service, the charity founded by Luke Gamble MRCVS to support animal welfare charities globally, is celebrating a donation of products including dog and cat wormers, skin and joint supplements and NSAIDs, by Ceva Animal Health.
The donated products were dispatched to the WVS’s own centres and shelters in Thailand, including its 'Care for Dogs' shelter in Chiang Mai, Thailand, as well as to over 60 animal welfare charities around the world, all of which have registered a wish list of items to the WVS.
One of the charities that benefited from the company's donation of over 1,000 Milbactor worming tablets to the WVS was the Liberia Animal Welfare and Conservation Society (LAWCS). Dogs are often kept in horrendous conditions in Liberia and LAWCS provides responsible dog ownership education, free veterinary care and treatment and community outreach feeding programmes to pet owners. The WVS’s donation helped enable LAWCS to reach and provide free veterinary care and treatment to 420 dogs in the country.
Luke Gamble, chief executive and founder of WVS, said: "The donation from Ceva is fantastic and we can’t thank the company enough. Its support means so much to the charity and enables us to help animals in tough places where veterinary support is hard to find. Ceva has always supported WVS and its generosity in giving us another donation like this is simply amazing."
Cuneyt Seckin, managing director at Ceva Animal Health said: "Our donation to WVS helps charities and organisations whose veterinary resources can be scarce or extremely difficult to fund improve the welfare conditions of animals that are often kept in horrendous conditions.
"Treatments like wormers are the most requested items by WVS’s associated charities, so we are delighted that our donation has been able to impact the welfare of individual animals to greatly improve their quality of life."
There are four categories of award:
Veterinary practices who feel they have excellence to showcase are invited to submit their nominations via: https://spvs.org.uk/business-excellence-awards, highlighting why they deserve to receive the award against each of the selection criteria.
The deadline for nominations is 5pm on 31st October 2023.
The SPVS Board then will review submissions and shortlist the top 5 nominations in each category.
Shortlisted practices will be contacted by 5pm on the 15th November 2023, and invited to submit a more detailed statement of 750 words or a 90-second video, giving them another opportunity to showcase their accomplishments.
A panel of SPVS members will evaluate the final submissions and vote for a winner in each category.
Category winners will be announced before the end of the year, and will win full day + evening tickets to SPVS Congress 2024 on Thursday 25th January 2024 for three team members, plus overnight accommodation at the Hilton Birmingham Metropole.
The overall winner will be announced at the SPVS Congress 2024 opening ceremony (25th – 27th January 2024).
As part of its ongoing "Excellence in veterinary anaesthesia" initiative, and following the launch of Alfaxan, Vetoquinol has published a summary of the latest expert recommendations concerning anaesthesia in cats and dogs in a new document: Premedication and anaesthesia in dogs and cats.
The publication covers the pre-medication and pre-anaesthetic period, the induction and maintenance of anaesthesia and the recovery period as well as useful A-Z list of specific case pre-medication and anaesthesia management recommendations (brachycephalic animals, caesarean operation, paediatric cases, renal disease, to name just a few).
The recommendations contained in the document were drawn up following a meeting in February at which a panel of experts discussed all aspects of anaesthesia for dogs and cats, focussing particularly on pre-medication.
The panel was comprised of: Dr Jo Murrell of Bristol University; John Hird of the Hird Consultancy; Dr Mark Senior of University of Liverpool; Dr Polly Taylor, Independent anaesthesia consultant; Elizabeth Leece of the Animal Health Trust; Dr Jackie Brearley of Cambridge Vet School; Daniel Holden , Independent anaesthesia consultant, Prof. Eddie Clutton of Edinburgh University and Elizabeth Chan of the Royal Veterinary College.
"We were delighted to have gathered such an authoritative panel of veterinary anaesthesia experts," said Zorica Agbaba of Vetoquinol, who hosted the meeting. "I am sure that the recommendation document will prove invaluable to vets in general practice."
The document is available from Vetoquinol UK and Ireland, please contact your local Vetoquinol representative or alternatively call Vetoquinol's main office on 01280 814 500 (UK) or 1800 406 117 (ROI free phone number).
Intervet/Schering-Plough Animal Health has launched the Intestinal Health Center for Poultry website (www.ihc-poultry.com), a website to keep producers, veterinarians, nutritionists, academics and students informed about this aspect of poultry production.
The company says it has published a wealth of practical, science-driven information and ideas to help producers manage costly gut diseases more effectively through vaccination, nutrition, sanitation and prudent drug use.
Marcelo Lang, global marketing director for the company's Poultry Business Unit said: "The new website lets you find virtually anything you need, quickly and easily, on specific intestinal health topics and products".
The website also offers a library of past issues of the company's Intestinal Health magazine and its predecessor, CocciForum, as well as three newsletters - Broiler Health, Layer Health and Turkey Health. In addition, the website includes an interactive feature called "Gut Reactions," where visitors can answer a frequently updated questionnaire related to intestinal health, immediately view survey results and then access links with more information on that topic. There is also a product finder to help users find Intervet/Schering-Plough Animal Health intestinal health products available in their market.
Marcelo added: "The Intestinal Health Center for Poultry is another example of Intervet/Schering-Plough Animal Health's commitment to educating the industry about this increasingly important segment of poultry health. We look forward to getting feedback on the site so that we can make it even better."
Davies Veterinary Specialists (DVS), the private small animal referral centre based in Hertfordshire, has installed two new state-of-the-art ESAOTE ultrasound machines.
DVS says The MyLab Twice Vet and the MyLab Class C Vet provide fast, efficient and highly accurate imaging in a wide range of applications, including high-definition abdominal, cardiac, musculoskeletal and ophthalmic scans.
The MyLab Twice Vet, with its range of probes including the broadband 18MHz linear probe, will be used for general ultrasonographic imaging at DVS. It is capable of the most refined contrast media examinations that, for example, can help to locate and identify a liver tumour that may be rendered invisible when using conventional diagnostic procedures.
The MyLab Class C will be used predominantly for advanced cardiac work, including trans-oesophageal echocardiography for interventional procedures in theatre.
Pedro Oliveira, European Veterinary Specialist in Cardiology at DVS said: "The trans-oesophageal probe is currently a very rare piece of equipment in veterinary diagnostics. It gives us the capacity to obtain unique views of the heart, especially the heart base which can be a very difficult area to examine with regular echocardiography. It also allows real-time and direct monitoring of procedures, such as deployment of devices to occlude patent ductus arteriosus, surgery and anaesthesia in critical patients."
The first patient to benefit from the new My Lab Class C was an 11-year-old, female German shepherd dog with suspected cardiac neoplasia following several episodes of haemorrhage into the pericardium. A normal echocardiographic examination identified a small suspect area but it was in a part of the heart that was very difficult to approach surgically.
However, a trans-oesophageal examination revealed that another small mass close to the tip of the right auricle was actually the origin of the bleeding. The dog underwent surgery to remove the mass and subsequently made a full recovery. Without the My Lab Class C there would have been no viable options for this dog.
Clive Elwood, Managing Director at DVS, said: "Combining the best possible on-site diagnostic equipment with some of Europe's finest clinicians enables us to provide the best possible service and outcome for our patients, across multiple disciplines."
As of the start of this week, police forces and local authorities have new legal powers designed to reduce the number of dog attacks.
For the first time, police and local authorities will be able to demand that owners take action to prevent a dog attack or risk fine of up to £20,000. If a complaint has been made about a dog to the council or police, its owners can be ordered to do any or all of the following:
The government has published a manual called Dealing with irresponsible dog ownership: practitioner's manual, to guide police forces and local authorities in the use of their new legal powers to prevent dog attacks.
Animal Welfare Minister Lord de Mauley said: "Dog attacks are devastating for victims and their families which is why we are taking tough action against those who allow them to happen. Police and local authorities will now have more powers to demand that irresponsible dog owners take steps to prevent attacks before they occur. This is on top of the tougher prison sentences we introduced earlier this year for owners who allow their dogs to attack people and assistance dogs."
The National Policing Lead for Dangerous Dogs, DCC Gareth Pritchard said: "The Practitioners Manual gives police officers and other practitioners clear guidance on how to best implement the legislative changes, especially the early preventative measures such as Community Protection Notices, to help prevent more serious events occurring in the future. It also provides a platform to share good practice between police forces and partner agencies and it will form part of the ongoing training of Dog Legislation Officers across England and Wales."
Photo credit: iStockphoto/Thinkstock.
The guidelines, which have produced by a panel of clinicians and analgesia researchers, summarise the current evidence and offer expert opinion and best practice recommendations for the use of analgesics for common scenarios.
Recommendations include:
Professor Celia Marr, Editor of the EVJ said: "The BEVA primary care clinical guidelines provide up-to-date clarity on the fundamental aspects of equine pain management for the clinician and are essential reading for all those in first opinion ambulatory roles."
The guidelines are the first in a series being produced for primary care vets by BEVA. They can be downloaded here: https://beva.onlinelibrary.wiley.com/doi/10.1111/evj.13198
Vets Now Limited, the out-of-hours emergency care provider, has been announced as a finalist in the Scottish region of the Bank of Scotland Corporate £35 Million Entrepreneur Challenge. The company will now compete with four other businesses to secure a funding package of up to £5 million, free of interest and charges for three years.
Managing Director, Richard Dixon, must now present his business case to a judging panel featuring two well known and incredibly successful entrepreneurs. Willie Haughey from City Refrigeration and John Anderson from The Entrepreneurial Exchange will be joined on the panel by senior representatives from Bank of Scotland Corporate and Deloitte. The panel will be grilling all five finalists on their future business plans, as well as looking for someone with an entrepreneurial flair, spirit and vision that sets them apart from the rest and makes them an outstanding choice to receive the once in a lifetime funding package that could change the face of the business.
The judging process will take place on Thursday 2 October and will be followed that evening by a dinner and award ceremony at Stirling Castle, where the winner will be announced.
For more information visit http://www.theboschallenge.co.uk/
The RCVS is seeking nominations for its 2014 Honours and Awards Round, and wants to hear about any individuals, of whatever age or experience, who have made an outstanding contribution to the profession.
The annual Honours scheme comprises two distinct and prestigious types of award: Honorary Fellowships for RCVS-registered veterinary surgeons and Honorary Associateships for non-veterinary surgeons. Both sets of awards are presented each year at RCVS Day - the College's AGM and award ceremony in London.
The College says it is keen for the Fellowship nominations net to be cast as widely as possible in order to offer recognition of veterinary achievements not only in more traditional fields like academia and clinical practice, but also in science, education, industry and politics.
In addition, Honorary Fellowship nominees no longer need to have been an RCVS member for 30 years, meaning that younger veterinary surgeons who have gone significantly above and beyond the call of duty will also be eligible for consideration.
Honorary Associateships are intended to celebrate the achievements of those who have contributed to the health and welfare of animals by working in fields related to the veterinary profession, and could be from a similarly wide range of backgrounds, for example, veterinary nurses, scientists, lecturers, farriers, charity workers, farmers, conservationists or those in industry and commerce.
Nick Stace, RCVS Chief Executive, said: "At my first RCVS Day this summer, I was hugely impressed with the calibre of candidates who received our awards, and delighted we were able to formally mark their achievements. The veterinary profession has a lot of talented people who deserve to be recognised for the contribution they have made, whether in science and academia, or in politics and clinical practice. Everyone knows someone who is worthy of this kind of recognition and I urge you to take the next step and nominate them for an award."
There are no restrictions on who can make a nomination, although the closing deadline is 13 September 2013. Full details on how to make a nomination are available at www.rcvs.org.uk/honours.
Genitrix has launched a new system called Osteokine, which produces Platelet-Rich-Plasma (PRP). PRP, an autologous solution containing therapeutically significant concentrations of platelets, is known to accelerate the healing of injuries and is already widely used in human medicine. It is increasingly being used in the treatment of horses.
The Osteokine system, developed by German company Orthogen which also manufactures joint therapy Irap, comprises two interconnected blood bags.
The system involves taking citrated whole blood from the horse and placing it into the first, red-capped Osteokine bag for processing in a centrifuge. The plasma and platelets are then transferred to the second bag, and a second centrifuge process separates the plasma and generates a pellet of PRP, which is extracted and used to treat the horse from which it was taken.
Treatment with PRP has been shown to accelerate wound healing in all kinds of tissue particularly tendons and ligaments and has also been used in bone healing. It has been noted to reduce perioperative traumatic pain while the higher collagen content provided by PRP can create improved scar resistance.
Commenting on the launch of the Osteokine system in the UK, Rob Watkins, Marketing Director of Genitrix, said: "Therapeutic care of equine lameness is an area of particular expertise for Genitrix and the innovative treatments we've brought to market, including Acell, HY50 and Irap already form part of the staple ‘toolkit' of many equine vets.
"The benefits of PRP in terms of accelerating wound healing and vasculerisation are already widely accepted as are the advantages of an autologous approach in terms of eliminating the risk of disease transmission. To date, however, the process of extracting PRP has proved complex and expensive and only provided in specialised laboratories.
"Osteokine, in contrast, offers a cost-effective approach based on a system which is simple to operate in practice and takes only 20 minutes. We believe it offers a highly effective approach to treating wounds and injuries in horses."
For further information on Osteokine, contact Genitrix on 01403 786345.
Novartis Animal Health UK has announced that it is committed to maintaining a reliable supply of Bovidec BVD virus vaccine throughout the coming season.
The announcement comes following concerns surrounding the availability of BVD vaccines. Novartis Brand Manager Eugene Smyth said: "We have been in discussion with the regulatory authorities to try and ensure we can meet the demand over the coming months and we have a large team of territory managers and technical services veterinarians dedicated to supporting our customers through the season".
Bovidec BVD virus vaccine, immunises adult cattle against the BVD Type 1 virus and for active immunisation of calves against BVD Type II virus.
Guillaume Fournié and Dr Javier Guitian from the Royal Veterinary College - working with colleagues from the London School of Hygiene and Tropical Medicine and Imperial College - have developed a model to understand how live bird markets act as a "hub" of infection for domestic poultry and if rest days, during which such markets are emptied and disinfected, may reduce transmission.
The results are published today in Interface - the Journal of The Royal Society. PhD student Guillaume Fournié, who led the research, said: "Live bird markets can be a reservoir of infection for domestic poultry and may therefore be responsible for sustaining H5N1 HPAI virus circulation.
"Compared to interventions applied in farms - such as stamping out and vaccination - our model shows that frequent rest days are an effective means with which to reduce H5N1 HPAI infection rates. Furthermore, our model predicts that full market closure - as has been implemented in some countries such as Egypt and Vietnam - would only be slightly more effective than rest days to reduce transmission of the disease."
The models used in the study are based on the live bird market chain in Hong Kong and the analysis restricted to chickens. Fournié, who qualified to be a vet in Alfort in his native France, was awarded fully-funded studentships (tuition fees and a living allowance) in 2007 by The Bloomsbury Colleges - a consortium of six colleges of the University of London: Birkbeck, IoE, LSHTM, RVC, School of Oriental and African Studies, and The School of Pharmacy - to conduct the research.
Since December 2003 outbreaks of H5N1 Highly Pathogenic Avian Influenza (HPA1) affecting domestic poultry have been reported in 50 countries across the world. Massive economic losses and the pandemic threat make H5N1 HPAI one of the greatest current public health concerns.
A full copy of the report can be seen in Interface at http://rsif.royalsocietypublishing.org
The RCVS has appointed Amanda Boag as its new Treasurer, replacing Dr Bradley Viner who will become (junior) Vice-President in July.
Amanda will officially take up her post at RCVS Day - the College's Annual General Meeting and Awards Day - on Friday 11 July.
Amanda is a Clinical Director at Vets Now and is also currently President of the European Society of Veterinary Emergency and Critical Care. She was elected to RCVS Council for a four-year term in 2012.
As Treasurer she will be responsible for maintaining an overview of the College's affairs, ensuring its financial viability and making sure that proper financial records and procedures are maintained.
Amanda said: "I am very honoured to have been appointed Treasurer for the RCVS and am looking forward to working closely with other Council members and the Belgravia House team.
"I would particularly like to thank my predecessor Bradley Viner for the excellent work he has done over the past four years. This has been a period of great change for the College and during his tenure he has done a huge amount of work to support the improvements in governance, including standardising the way that the College's accounts are reported.
"Our finances are currently in a healthy state despite no increase in the annual renewal fee for several years. I am now looking forward to building on his legacy and ensuring the finances remain healthy, allowing us to move forward with our Strategic Plan."
At RCVS Day on 11 July, Professor Stuart Reid will also be confirmed as President; current President Neil Smith as (senior) Vice-President; Chris Tufnell as Chairman of the Education Committee; and David Catlow as Chairman of the Standards Committee.
Ceva Animal Health, maker of Milbactor, Vectra 3D and Vectra Felis, has launched a new booklet for practices to give clients: Protecting your Pet from Parasites.
The booklet offers an overview of the common ecto and endoparasites that can affect dogs and cats in the UK, including fleas, ticks, roundworm, tapeworm and lungworm. It explains how pets can become infested, how to tell if a pet is infected and the potential health problems that may result from an infestation. It also highlights the importance of routine treatment to help prevent infestation and transmission of diseases.
At the end of the booklet there is a check list designed to help pet owners and their vets determine the parasites that pose the greatest threat to their pet, taking into account factors such as whether there is more than one pet in the household, whether the pet scavenges or hunts wildlife or whether there are children in the household.
Rob McLintock MRCVS, companion animal business unit manager at Ceva Animal Health said: "Recent research1 carried out by Ceva demonstrated that pet owners are increasingly confused by what parasites are being treated by their current anti-parasitic regime. The new booklet will provide owners with a comprehensive overview of both ectoparasites and endoparasites and facilitate discussion between clients and their vets to assess the best treatments on a case by case basis."
Ceva has recently launched the Ceva Protection System for dogs, a simple two-step solution featuring Milbactor and Vectra 3D to provide comprehensive ectoparasite and endoparasite protection with one monthly topical treatment and one flavoured tablet. The Ceva Protection System also features Vectra Felis, offering fast-acting flea protection for cats, and Acclaim® for sustained treatment of the pet's home environment.
To request copies of the booklet, call Ceva Animal Health on 01494 781510 or contact your local Ceva Animal Health territory manager.
536 cat and dog owners, February 2015
PSS accredited practices are required to nominate an Appointed Senior Veterinary Surgeon, and under the RCVS Guidance, the College expects all veterinary service providers to do likewise.
Senior Veterinary Surgeons are responsible for making sure practice standards, policies and procedures are compliant with the Code and that legislation and guidance in areas such as veterinary medicines, consumer choice and professional autonomy are being met.
The new course outlines the roles and responsibilities of the appointed senior veterinary surgeon, with examples and scenarios drawn from the supporting guidance to the Code of Professional Conduct.
Clare Paget, RCVS Registrar and Director of Legal Services, said: “The role of appointed senior veterinary surgeon is an absolutely crucial one in the veterinary clinical practice setting.
"Having an appointed senior veterinary surgeon ensures that veterinary teams are working under the guidance and direction of a senior clinical figure and that there is someone who has overall accountability for standards at a practice.
"The appointed senior veterinary surgeon also has the important role of ensuring that the clinical judgement of the veterinary team is paramount over, for example, any commercial pressures.
“This course outlines the roles and responsibilities of the appointed senior veterinary surgeon and will help members of the vet team identify who they are within their organisation and, if relevant, recognise and implement the responsibilities of the role.”
The course takes around 30 minutes to complete, is free to access via the RCVS Academy, and counts towards annual continuing professional development (CPD) requirements for both veterinary surgeons and veterinary nurses.
academy.rcvs.org.uk
Dechra Veterinary Products is offering vets free Identichips® worth £100 when they order Equipalazone® Powder 100s. The European Union (EU) has now approved regulations that any equine foal born after July 1 2009 should be micro-chipped, and Defra is currently consulting with equine industry professionals about the best method of implementation. The combination of a micro-chip and horse passport provides a reliable method of identification and also a medical record. Larry King, Dechra's equine product manager said: "We want to make it easier for vets to offer clients the best method of identification and in turn, make it difficult for horses treated with veterinary medicines to enter the human food chain. "We are pleased to support the micro-chipping initiative and the Equine Passport Scheme with our Identichips offer and an owner leaflet about passports to promote responsible horse ownership. They will both help prevent important products like Equipalazone from inadvertently entering the food chain. He added: "We stand to lose up to 70 per cent of veterinary medicines if the industry and horse owners don't comply with EU legislation of horse passports and micro-chipping for every equine". The owner leaflet outlines the importance and benefits of the Equine Passport Scheme and is being inserted into every box of Equipalazone Powder 100s. Further copies are available from Dechra Veterinary Products for practices to distribute to their clients. Practices can claim their free Identichips by ordering boxes of Equipalazone Powder 100s from Rachel Horton at Dechra Veterinary Products on 01743 452 847 before August 31 2008.
Vets Now, the out-of-hours emergency services provider is to launch the Vets Now Hospital service in Glasgow city centre, where it will offer emergency and critical care together with a range of specialist referral options.
This follows on the heels of The University of Glasgow Small Animal Hospital, a new £15 million facility which opened at the end of August.
Vets Now says that the new hospitals and the range of clinical services on offer to the profession and pet owners will make the west of Scotland a centre of excellence in advanced clinical care for animals.
The opening of the two facilities will also offer both organisations a new platform on which to develop further their long standing relationship through future collaboration in the areas of teaching, training and investigation into animal disease.
Vets Now Group Managing Director, Richard Dixon said: "The opening of the two facilities presents a number of opportunities for both organisations to work collaboratively to develop teaching and training for undergraduates, residents, interns and nurses, and to work together to gain further understanding into animal disease through clinical investigation and the practice and promotion of evidence based medicine."
Professor Stuart Reid, Dean of the Faculty of Veterinary Medicine at the University said: "The expanded service which will be offered by the Small Animal Hospital and the new Vets Now Hospital obviously presents an enhanced range of choices for pet owners and first opinion vets in Scotland and an opportunity for both organisations to work collaboratively to ensure that undergraduates and clinical professionals have access to the best training and opportunities to develop professionally. We have enjoyed a mutually beneficial relationship for a number of years and we look forward to the new opportunities which the opening of the two hospitals will bring in the future."
The Small Animal Hospital opened on 31 August. The first Vets Now Hospital will open in Glasgow on 31 October.
Vetoquinol is offering veterinary surgeons and nurses the chance to win up to £500 worth of vouchers of their choice with Ipakitine, the phosphate binder.
To take part, call 0800 1698197 and request a copy of the company's renal guide, wall chart and an entry form. Then answer three simple questions and be in with a chance to win a first prize of £500 worth of vouchers. The second prize is £300 worth of vouchers, with £200 of vouchers for third prize.
Simon Boulton, product manager said: "Our renal guide is designed to illustrate factors which can affect both quality and quantity of life. These include hyperphosphataemia, hypertension, proteinuria, azotaemia and fibrosis in renal disease." The renal guide and wall chart contain information on the appropriate management of these factors.
The PDSA has announced the start of its annual pet slimming competition, and revealed the 17 competitors who will be fighting to win the title of Pet Fit Club Slimmer Of The Year.
The competition is run to highlight the high level of pet obesity in the UK. According to the charity, around a third of all dogs (2.5M) and a quarter of all cats (2M) are estimated to be overweight.
PDSA research has shown that 87% of owners give their pets treats, despite the fact that 91% realise the resulting obesity can reduce their pet's lifespan. The PDSA's PAW Report, produced in conjunction with YouGov, discovered that a wide range of inappropriate treats are being fed to pets, including fast food, leftovers, crisps, biscuits, chocolate and chips.
Elaine Pendlebury, PDSA Senior Veterinary Surgeon, said: "Obesity is one of the biggest welfare issues affecting pets in the UK today. Sadly, it also means millions of pets are at risk from potentially life-threatening health problems related to obesity."
For more information about the finalists, please visit www.pdsa.org.uk/petfitclub
The papers in the report cover things like: novel, 3D-printed anatomical implants for orthopaedics, osteoarthritis and clinical outcomes measures, movement disorders and Quality Improvement in cruciate ligament surgery.
John said: "For an independent veterinary practice to publish a report like this is, in my experience, novel, and it speaks to the culture and values of our practice.
"All of the references cited in the report are clinical research outputs that are directly relevant to practising vets so I hope this will be a useful collated resource.”
https://www.movementvets.co.uk/about-us/clinical-research
Bayer Animal Health, manufacturer of Advocate, is launching an advertising campaign to support its 'Be Lungworm Aware' initiative, which aims to educate pet owners on the spread of Angiostrongylus vasorum and encourage them to seek advice from their local veterinary practice.
The campaign will see a new TV 'public information' style advertisement targeting dog owners. It will air on 20 national TV channels during April including ITV1, 2 and 3, Sky 1, 2 and 3, More 4 and Film4, with air time dedicated to GMTV and daytime ITV.
The TV advertising campaign will focus on the parasite's intermediate hosts - slugs and snails - and the ease in which dogs can become infected with the parasite by picking up something as simple as a toy with a slug attached to it.
Print advertisements will also be running in national newspapers and women's consumer magazines with a focus on publications read by pet owners.
Marketing support material is available for veterinary practices wishing to participate in the 'Be Lungworm Aware' initiative. For further details, or to order the new practice materials, please contact your Bayer representative or ring 0845 2574798 quoting 'Be Lungworm Aware'.